Candida albicans secreted protease Sap6 engages epithelial protease-activated receptors PAR2 and NLRP3
白色念珠菌分泌的蛋白酶 Sap6 与上皮蛋白酶激活受体 PAR2 和 NLRP3 结合
基本信息
- 批准号:10300121
- 负责人:
- 金额:$ 23.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:ApoptosisAspartic EndopeptidasesBacteriaBindingBinding SitesBlocking AntibodiesCASP1 geneCalcium SignalingCandida albicansCandidiasisCarbohydratesCaspaseCatalytic DomainCell Surface ReceptorsCell WallCell surfaceCellsCellular MorphologyDataDisseminated candidiasisE-CadherinElectrical ResistanceEndocytosisEpithelialEpithelial CellsFOS geneFilamentFoundationsFungal ProteinsFutureGoalsHumanHyphaeIL17 geneIL8 geneImmunityImmunocompromised HostInflammasomeInflammationInflammatory ResponseIntegrin BindingIntegrinsInterleukin-1 betaKnockout MiceMeasurementMeasuresMediatingMorphologyMucous MembraneMycosesNeutrophil InfiltrationOpportunistic InfectionsOralPathogenicityPattern recognition receptorPeptide HydrolasesPeptidesPermeabilityPhosphorylationProductionProteinase-Activated ReceptorsProteinsRGD (sequence)Receptor SignalingRoleSignal PathwaySignal TransductionSiteSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSurfaceSymbiosisTestingTherapeuticVirulenceWorkYeastsarmcytokinefungusgut microbiotain vivo Modelmembermonocytemycobiomenoveloccludinoral bacteriaoral cavity epitheliump38 Mitogen Activated Protein Kinasepathogenic fungusreceptorreceptor internalizationrelease of sequestered calcium ion into cytoplasmtreatment strategy
项目摘要
Candida albicans pathogenicity is associated with its morphological transformation from yeast to
production of filamentous hyphae. Secretion of hyphal-specific proteins, particularly the aspartyl
protease Sap6, is a key marker of its transition from commensalism to virulence. Sap6 contains
both a proteinase domain and an RGDRGD integrin-binding motif adjacent to its catalytic domain.
We found that rSap6 added to primary oral epithelial cells (OECs) elicited IL1β secretion typical of
NLRP3 signaling but also produced IL-8. Sap6 added to OECs induced phosphorylation of p38 and
IL-8 production through the protease- activated receptor (PAR2). PAR2 signaling was lost upon heat
inactivation of Sap6, while NLRP signaling was reduced upon deletion of Sap6 RGD-binding sites,
leading to our hypothesis that both Sap6 proteolytic and RGD-mediated mechanisms are involved in
sensing levels of this fungal secreted protein by OECs. We will test this hypothesis by identifying the
proteolytic mechanism for Sap6 activated PAR2 MAPKinase signaling in OECs in Aim1, and
assessing the contribution of the Sap6 integrin-binding RGD motif in NLRP3 inflammasome
activation and apoptosis in Aim 2. This work will establish PAR2 and integrin/NLRP3 as cell surface
receptors for C. albicans Sap6 and define their role in modulating host inflammatory responses to
fungal proteins in OECs. The long-range goal of this project will be to activate/deactivate PAR2
receptors or NLRP3 signaling as a means of modulating host inflammation as an avenue for
treatment of candidiasis.
白色念珠菌的致病性与其从酵母菌到
丝状菌丝的产生。菌丝特异性蛋白质的分泌,特别是
蛋白酶Sap 6是其从嗜热性向毒力转变的关键标志。sap 6包含
蛋白酶结构域和邻近其催化结构域的RGDRGD整联蛋白结合基序。
我们发现,rSap 6加入到原代口腔上皮细胞(OECs)中可引起典型的IL 1 β分泌,
NLRP 3信号传导,但也产生IL-8。向OECs中加入Sap 6诱导p38磷酸化,
通过蛋白酶激活受体(PAR 2)产生IL-8。PAR 2信号传导在加热时丢失
Sap 6的失活,而NLRP信号传导在Sap 6 RGD结合位点缺失后减少,
这导致我们假设Sap 6蛋白水解和RGD介导的机制都参与了
通过OECs检测这种真菌分泌蛋白的水平。我们将通过识别
Aim 1中OEC中Sap 6激活PAR 2 MAP激酶信号传导的蛋白水解机制,以及
评估NLRP 3炎性体中Sap 6整联蛋白结合RGD基序的贡献
Aim 2中的活化和凋亡。这项工作将建立PAR 2和整合素/NLRP 3作为细胞表面
C.白色念珠菌Sap 6,并确定其在调节宿主炎症反应,
OECs中的真菌蛋白。本项目的长期目标是激活/停用PAR 2
受体或NLRP 3信号传导作为调节宿主炎症的手段,
治疗念珠菌病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mira Edgerton其他文献
Mira Edgerton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mira Edgerton', 18)}}的其他基金
Candida albicans oral infection shapes innate immunity and recruitment of myeloid-derived suppressor cells
白色念珠菌口腔感染塑造先天免疫和骨髓源性抑制细胞的募集
- 批准号:
10501899 - 财政年份:2022
- 资助金额:
$ 23.93万 - 项目类别:
Candida albicans oral infection shapes innate immunity and recruitment of myeloid-derived suppressor cells
白色念珠菌口腔感染塑造先天免疫和骨髓源性抑制细胞的招募
- 批准号:
10665797 - 财政年份:2022
- 资助金额:
$ 23.93万 - 项目类别:
Candida albicans secreted protease Sap6 engages epithelial protease-activated receptors PAR2 and NLRP3
白色念珠菌分泌的蛋白酶 Sap6 与上皮蛋白酶激活受体 PAR2 和 NLRP3 结合
- 批准号:
10428637 - 财政年份:2021
- 资助金额:
$ 23.93万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
2449485 - 财政年份:1999
- 资助金额:
$ 23.93万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
6164397 - 财政年份:1999
- 资助金额:
$ 23.93万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
6516337 - 财政年份:1999
- 资助金额:
$ 23.93万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
6362916 - 财政年份:1999
- 资助金额:
$ 23.93万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
6634566 - 财政年份:1999
- 资助金额:
$ 23.93万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
2015439 - 财政年份:1997
- 资助金额:
$ 23.93万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
2856658 - 财政年份:1997
- 资助金额:
$ 23.93万 - 项目类别:














{{item.name}}会员




